Provided by Tiger Trade Technology Pte. Ltd.

InspireMD

1.73
-0.0200-1.14%
Post-market: 1.730.00000.00%16:10 EST
Volume:16.19K
Turnover:28.31K
Market Cap:73.30M
PE:-2.10
High:1.82
Open:1.74
Low:1.72
Close:1.75
52wk High:3.80
52wk Low:1.51
Shares:42.37M
Float Shares:27.31M
Volume Ratio:0.92
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8242
EPS(LYR):-0.7633
ROE:-87.61%
ROA:-45.46%
PB:1.14
PE(LYR):-2.27

Loading ...

InspireMD participates in a conference call with Lake Street

TIPRANKS
·
Feb 12

Top InspireMD Executive Makes Attention-Grabbing Stock Move

TIPRANKS
·
Feb 03

InspireMD Announces Inducement Grants for New Employee

Reuters
·
Jan 20

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jan 20

InspireMD Reports C-GUARDIANS Trial Shows Lowest Adverse Event Rates for Carotid Stenting

Reuters
·
Jan 12

Is InspireMD (NASDAQ:NSPR) In A Good Position To Invest In Growth?

Simply Wall St.
·
Dec 24, 2025

InspireMD Grants Equity Awards and Extended Options to Departing Board Member

Reuters
·
Dec 20, 2025

InspireMD Director Paul Stuka Reports Acquisition of Common Shares

Reuters
·
Dec 12, 2025

Lake Street Reaffirms Their Buy Rating on InspireMD (NSPR)

TIPRANKS
·
Nov 24, 2025

InspireMD announces publication of CREST-2 data in NEJM

TIPRANKS
·
Nov 24, 2025

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Nov 21, 2025

InspireMD Inc’s Earnings Call: Growth Amid Challenges

TIPRANKS
·
Nov 05, 2025

InspireMD Reports Record Q3 Revenue with U.S. Launch

TIPRANKS
·
Nov 05, 2025

InspireMD Q3 revenue beats estimates on commercial launch of CGuard Prime

Reuters
·
Nov 04, 2025

InspireMD Q3 EPS $(0.17) Beats $(0.23) Estimate, Sales $2.523M Beat $1.760M Estimate

Benzinga
·
Nov 04, 2025

InspireMD Q3 Gross Profit USD 864 Thousand

THOMSON REUTERS
·
Nov 04, 2025

InspireMD Q3 Basic EPS USD -0.17

THOMSON REUTERS
·
Nov 04, 2025

InspireMD (NSPR) Receives a Buy from Lake Street

TIPRANKS
·
Nov 04, 2025

InspireMD Names Peter a. Soukas, M.d., as Chief Medical Officer

THOMSON REUTERS
·
Nov 03, 2025

Press Release: InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer

Dow Jones
·
Nov 03, 2025